Merkel cell carcinoma (MCC) is a highly malignant neuroendocrine non melanoma skin cancer, which is associated with the Merkel cell polyoma virus (MCPyV) 
Introduction
Merkel cell carcinoma (MCC) is a highly malignant non melanoma skin cancer characterized by the expression of neuroendocrine markers, i.e. CD56, chromogranin A and synaptophysin and a typical dotlike perinuclear expression of cytokeratin 20 (CK20) (1) . MCC occurs mainly in elderly or immunosuppressed patients and its clinical prognosis is very poor (1) .
The recent finding of the Merkel cell polyomavirus (MCPyV) in MCC has substantially contributed to the understanding of the etiopathogenesis of this malignancy (2) . Since 2008 MCPyV DNA has been detected in approximately 80% of more than 1000 MCCs yet tested.
MCPyV has been shown to be integrated in the MCC genomes by diverse molecular techniques (2) (3) (4) (5) (6) .
MCC was first introduced by Toker in 1972 as a trabecular carcinoma of the skin (7) . Dense core granules were identified in 3 MCCs which was confirmed by subsequent immunohistochemical studies testing neuroendocrine and simple epithelium markers (8) (9) (10) (11) (12) (13) . Based on the similarity of the expression patterns, MCC is considered to be most closely related to Merkel cells, which are located at the epidermal dermal junction and are supposed to function as noticeptive receptors of the skin. However, serious doubts on this theory have been postulated -also based on histomorphological growth patterns-and an alternative proposal suggesting a role for a pluripotent stem cell in the dermis as cells of origin of MCC still remains to be proven (14) .
In the past years, evidence is accumulating that MCC express early B cell lineage markers (15) (16) (17) (18) (19) (20) (21) (22) . For example, specific expression of terminal desoynucleotidyl transferase (TdT) as assessed by immunohistochemistry, which normally is restricted to thymocytes and precursors of lymphocytes in the bone marrow, has been reported in 72.5% (95/131) of MCCs (15) (16) (17) (18) (19) .
In addition, a number of studies have reported immunostaining of the B-cell specific activating protein (BSAP; syn: PAX5) in 83.6% (102/122) of MCCs (16, (19) (20) (21) (22) 
Materials and Methods

Patients and tissues
Formalin-fixed and paraffin-embedded (FFPE) tissues of resection specimens of 21 MCCs were included in this study. All respective tumors had been excised for diagnostic and Table 1 . Serial sections of all specimens were used for H&E staining, immunohistochemistry and DNA isolation. 
DNA extraction and immunglobulin light chain restriction
First, an H&E stain of the selected specimens was reviewed (V.W., A.z.H). Five 10µm-thick consecutive sections were cut from each paraffin block of formalin-fixed tissue and if needed microdissection was performed. After deparaffinization, the tissues were lysed by proteinase K overnight until complete tissue lysis, and DNA was extracted using QUIAmp mini kit 
Results
MCPyV, PAX5 and TdT expression in MCCs
The presence of MCPyV was assessed by the expression of the large T antigen (LTAg) as tested by immunohistochemistry. Eighteen MCCs (85.7%) were tested positive for LTAg expression. Of the 21 MCCs, 13 revealed very strong nuclear expression of the LTAg, 2 moderate nuclear expression and 3 weak nuclear expression ( Fig. 1 ; Table 1 ). In these MCPyV-positive cases LTAg expression was homogenous and found in all tumor cells. Three MCCs were completely negative for LTAg expression.
Specific nuclear expression of PAX5 was seen in all MCCs, of which 10 MCCs revealed strong PAX5 expression, 6 moderate and 5 weak (Table 1 ).
Specific nuclear TdT expression was detected in 16 MCCs (76.2%), of which 6 were strongly, 2 moderately and 8 weakly expressing TdT. Five MCCs were completely negative for TdT expression. Although no correlation was observed between PAX5, TdT and LTAg expression it is of interest that when PAX5 expression was high, TdT expression was low and vice versa. MCCs could be grouped according to TdT and PAX5 expression (see Tabel 1): TdT high, PAX5 low expression and TdT expression equally to PAX5 expression. In addition the third and also largest group of MCC showing a lower TdT expression compared to PAX5 expression. Table 1 . Noteworthy, all of the MCPyV-negative MCC (n= 3) did not show expression of Ig or kappa or lambda.
Expression of immunoglobulins and kappa and lambda in MCCs
Molecular testing of IgH and Igk rearrangement in MCCs
According to the specimen control size ladder 18 of the 21 MCCs revealed sufficient DNA quality to proceed with molecular testing ( 
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